Emergency Care Action Plans for Infants With Medical Complexity

Status Not yet recruiting

Clinical Trial Summary

An Emergency Care Action Plan (ECAP) is a tool intended to be helpful to providers when treating a child with complex medical needs during an emergency. Once created, ECAPs are added to the Electronic Health Record (EHR), shared with the child's caregiver(s), and kept up by all of those involved in a child's care. The goal of this study is to measure important health outcomes (ex. inpatient days, emergency department visits) in terms of the use of the ECAP for infants discharged from the Neonatal Intensive Care Unit (NICU). This study will also measure other real-time potential challenges related to the use of the ECAP including, but not limited to, if it is being used, if providers and caregivers want to use it, and if they keep using it over a long period of time.

Clinical Trial Description

National expert recommendations and human-centered design principles were used to optimize an Emergency Care Action Plan (ECAP) for infants with medical complexity. This study will implement and monitor the effectiveness and feasibility of the optimized Emergency Care Action Plan for infants with medical complexity. The primary objective is to determine the effectiveness of a user-centered Emergency Care Action Plan for infants with medical complexity on emergency health care utilization and cost metrics. The secondary objective is to monitor and evaluate barriers and facilitators to the current and widespread implementation of a user-centered Emergency Care Action Plan for infants with medical complexity. Research participants will be assigned by chance to receive an ECAP or standard care. Caregivers (parent/legal guardian) of infant participants will be asked to complete periodic surveys during a one-year feasibility trial period. If assigned, caregivers will be asked to help with the process of creating an ECAP for their child. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06444282
Study type	Interventional
Source	University of Vermont
Contact	Christian D Pulcini, MD, MEd, MPH
Phone	585-615-0381
Email	christian.pulcini@uvm.edu
Status	Not yet recruiting
Phase	N/A
Start date	August 1, 2024
Completion date	August 8, 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05552989` - Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
Not yet recruiting	`NCT04915690` - Investigation on the Practice Status of Emergency Stuff
Not yet recruiting	`NCT03424096` - Primary Palliative Care Education, Training, and Technical Support for Emergency Medicine	N/A
Completed	`NCT02534324` - The Effect of Pre-discharge Blood Pressure of Patients With Asymptomatic Severe Hypertension in Emergency Department	N/A
Completed	`NCT00991471` - The Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times	N/A
Recruiting	`NCT03257319` - Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department	Phase 3
Recruiting	`NCT05005117` - Laparoscopic Approach for Emergency Colon Resection	N/A
Recruiting	`NCT03917368` - Ultrasound Evaluation of the Jugular Venous Pulse (US-JVP)	N/A
Completed	`NCT04601922` - Qualitative Study of Long Term Cardiovascular Risk Prediction in the Emergency Department
Recruiting	`NCT05497830` - Machine Learning for Risk Stratification in the Emergency Department (MARS-ED)	N/A
Active, not recruiting	`NCT06220916` - The Greek Acute Dance Injuries Registry
Recruiting	`NCT05543772` - Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line	Phase 4
Recruiting	`NCT05496114` - Medical Checklists in the Emergency Department	N/A
Recruiting	`NCT06072534` - Evaluation of Effectiveness of Two Different Doses of Mivacurium in Rapid Sequence Intubation	N/A
Not yet recruiting	`NCT05528211` - Safety and Efficacy of Emergent TAVI in Patients With Severe AS
Completed	`NCT05818215` - Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Recruiting	`NCT04615065` - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Active, not recruiting	`NCT05221697` - Effect of an ML Electronic Alert Management System to Reduce the Use of ED Visits and Hospitalizations	N/A
Active, not recruiting	`NCT04648449` - Artificial Intelligence (AI) Support in Medical Emergency Calls
Not yet recruiting	`NCT04431986` - ER2 Frailty Levels and Incident Adverse Health Events in Older Community Dwellers

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.